|
Itraconazole Clinical Trials
11 actively recruiting trials across 8 locations
Also known as: Onmel, Sporanox, Tolsura
Other3 trials
Gilbert, Arizona1 trial
First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia
Banner MD Anderson Cancer Center
Phase 1/2
Scottsdale, Arizona1 trial
Phase 1
Tucson, Arizona1 trial
Phase 1/2
Cerritos, California1 trial
A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors
Helios Clinical Research
Phase 1/2
Palo Alto, California1 trial
A Phase II Trial to Evaluate the Effect of Itraconazole on Pathologic Complete Response Rates in Resectable Esophageal Cancer
VA Palo Alto Health Care System, Palo Alto, CA
Phase 2
Hartford, Connecticut1 trial
New Haven, Connecticut1 trial
A Study to Learn About How the Study Medicines Called Itraconazole and Probenecid Change How the Body Processes PF-07220060
Pfizer Clinical Research Unit - New Haven
Phase 1
Dallas, Texas1 trial
Evaluating the Effect of Itraconazole on Pathologic Complete Response Rates in Esophageal Cancer
Dallas VA Medical Center
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.